Peter M Irving (Peter Irving)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 47

Top Topics

Ulcerative Colitis

Top Venues

Alimentary pharmacology & therapeutics

Frontline gastroenterology

This page only lists publications with an associated author ORCID identifier.

Publications

Hannah K Systrom, Victoria Rai, Siddharth Singh, Leonard Baidoo, Adam S Cheifetz, Shane M Devlin, Krisztina B Gecse, Peter M Irving, Gilaad G Kaplan, Patricia L Kozuch, Thomas Ullman, Miles P Sparrow, Gil Y Melmed, Corey Allan Siegel
When Perfect Is the Enemy of Good: Results of a RAND Appropriateness Panel on Treat to Target in Asymptomatic IBD. The American journal of gastroenterology (2024)
Nicola J Wyatt, Hannah Fuller, Carl A Anderson, Nicholas Alexander Kennedy, Timothy Raine, Tariq Ahmad, Dean M Allerton, Michelle Bardgett, Emma Clark, Dawn Clewes, Cristina Cotobal, Mary Doona, Jennifer A Doyle, Katherine Frith, Helen C Hancock, Ailsa L Hart, Victoria Hildreth, Peter M Irving, Sameena Iqbal, Ciara Kennedy, Andrew King, Sarah Lawrence, Charlie W Lees, Robert Lees, Laura Letchford, Trevor Liddle, James O Lindsay, Rebecca H Maier, John C Mansfield, Julian R Marchesi, Naomi McGregor, Rebecca E McIntyre, Jasmin Ostermayer, Tolulope Osunnuyi, Nicholas Powell, Natalie J Prescott, Jack Satsangi, Shriya Sharma, Tara Shrestha, Richard Alexander Speight, Michelle Strickland, James M S Wason, Kevin Whelan, Ruth C Wood, Gregory R Young, Xinyue Zhang, Miles Parkes, Christopher J Stewart, Luke Jostins-Dean, Christopher Andrew Lamb
Defining predictors of responsiveness to advanced therapies in Crohn's disease and ulcerative colitis: protocol for the IBD-RESPONSE and nested CD-metaRESPONSE prospective, multicentre, observational cohort study in precision medicine. BMJ open 14 (4) (2024)
Nicola J Wyatt, Hannah Fuller, Carl A Anderson, Nicholas Alexander Kennedy, Timothy Raine, Tariq Ahmad, Dean M Allerton, Michelle Bardgett, Emma Clark, Dawn Clewes, Cristina Cotobal, Mary Doona, Jennifer A Doyle, Katherine Frith, Helen C Hancock, Ailsa L Hart, Victoria Hildreth, Peter M Irving, Sameena Iqbal, Ciara Kennedy, Andrew King, Sarah Lawrence, Charlie W Lees, Robert Lees, Laura Letchford, Trevor Liddle, James O Lindsay, Rebecca H Maier, John C Mansfield, Julian R Marchesi, Naomi McGregor, Rebecca E McIntyre, Jasmin Ostermayer, Tolulope Osunnuyi, Nicholas Powell, Natalie J Prescott, Jack Satsangi, Shriya Sharma, Tara Shrestha, Richard Alexander Speight, Michelle Strickland, James M S Wason, Kevin Whelan, Ruth C Wood, Gregory R Young, Xinyue Zhang, Miles Parkes, Christopher J Stewart, Luke Jostins-Dean, Christopher Andrew Lamb
Defining predictors of responsiveness to advanced therapies in Crohn's disease and ulcerative colitis: protocol for the IBD-RESPONSE and nested CD-metaRESPONSE prospective, multicentre, observational cohort study in precision medicine. BMJ open 14 (4) (2024)
Nicola J Wyatt, Hannah Fuller, Carl A Anderson, Nicholas Alexander Kennedy, Timothy Raine, Tariq Ahmad, Dean M Allerton, Michelle Bardgett, Emma Clark, Dawn Clewes, Cristina Cotobal, Mary Doona, Jennifer A Doyle, Katherine Frith, Helen C Hancock, Ailsa L Hart, Victoria Hildreth, Peter M Irving, Sameena Iqbal, Ciara Kennedy, Andrew King, Sarah Lawrence, Charlie W Lees, Robert Lees, Laura Letchford, Trevor Liddle, James O Lindsay, Rebecca H Maier, John C Mansfield, Julian R Marchesi, Naomi McGregor, Rebecca E McIntyre, Jasmin Ostermayer, Tolulope Osunnuyi, Nicholas Powell, Natalie J Prescott, Jack Satsangi, Shriya Sharma, Tara Shrestha, Richard Alexander Speight, Michelle Strickland, James M S Wason, Kevin Whelan, Ruth C Wood, Gregory R Young, Xinyue Zhang, Miles Parkes, Christopher J Stewart, Luke Jostins-Dean, Christopher Andrew Lamb
Defining predictors of responsiveness to advanced therapies in Crohn's disease and ulcerative colitis: protocol for the IBD-RESPONSE and nested CD-metaRESPONSE prospective, multicentre, observational cohort study in precision medicine. BMJ open 14 (4) (2024)
Nicola J Wyatt, Hannah Fuller, Carl A Anderson, Nicholas Alexander Kennedy, Timothy Raine, Tariq Ahmad, Dean M Allerton, Michelle Bardgett, Emma Clark, Dawn Clewes, Cristina Cotobal, Mary Doona, Jennifer A Doyle, Katherine Frith, Helen C Hancock, Ailsa L Hart, Victoria Hildreth, Peter M Irving, Sameena Iqbal, Ciara Kennedy, Andrew King, Sarah Lawrence, Charlie W Lees, Robert Lees, Laura Letchford, Trevor Liddle, James O Lindsay, Rebecca H Maier, John C Mansfield, Julian R Marchesi, Naomi McGregor, Rebecca E McIntyre, Jasmin Ostermayer, Tolulope Osunnuyi, Nicholas Powell, Natalie J Prescott, Jack Satsangi, Shriya Sharma, Tara Shrestha, Richard Alexander Speight, Michelle Strickland, James M S Wason, Kevin Whelan, Ruth C Wood, Gregory R Young, Xinyue Zhang, Miles Parkes, Christopher J Stewart, Luke Jostins-Dean, Christopher Andrew Lamb
Defining predictors of responsiveness to advanced therapies in Crohn's disease and ulcerative colitis: protocol for the IBD-RESPONSE and nested CD-metaRESPONSE prospective, multicentre, observational cohort study in precision medicine. BMJ open 14 (4) (2024)
Hannah K Systrom, Victoria Rai, Siddharth Singh, Leonard Baidoo, Adam S Cheifetz, Shane M Devlin, Krisztina B Gecse, Peter M Irving, Gilaad G Kaplan, Patricia L Kozuch, Thomas Ullman, Miles P Sparrow, Gil Y Melmed, Corey Allan Siegel
When Perfect Is the Enemy of Good: Results of a RAND Appropriateness Panel on Treat to Target in Asymptomatic Inflammatory Bowel Disease. The American journal of gastroenterology (2024)
Nicola J Wyatt, Hannah Fuller, Carl A Anderson, Nicholas Alexander Kennedy, Timothy Raine, Tariq Ahmad, Dean M Allerton, Michelle Bardgett, Emma Clark, Dawn Clewes, Cristina Cotobal, Mary Doona, Jennifer A Doyle, Katherine Frith, Helen C Hancock, Ailsa L Hart, Victoria Hildreth, Peter M Irving, Sameena Iqbal, Ciara Kennedy, Andrew King, Sarah Lawrence, Charlie W Lees, Robert Lees, Laura Letchford, Trevor Liddle, James O Lindsay, Rebecca H Maier, John C Mansfield, Julian R Marchesi, Naomi McGregor, Rebecca E McIntyre, Jasmin Ostermayer, Tolulope Osunnuyi, Nicholas Powell, Natalie J Prescott, Jack Satsangi, Shriya Sharma, Tara Shrestha, Richard Alexander Speight, Michelle Strickland, James M S Wason, Kevin Whelan, Ruth C Wood, Gregory R Young, Xinyue Zhang, Miles Parkes, Christopher J Stewart, Luke Jostins-Dean, Christopher Andrew Lamb
Defining predictors of responsiveness to advanced therapies in Crohn's disease and ulcerative colitis: protocol for the IBD-RESPONSE and nested CD-metaRESPONSE prospective, multicentre, observational cohort study in precision medicine. BMJ open 14 (4) (2024)
Nicola J Wyatt, Hannah Fuller, Carl A Anderson, Nicholas Alexander Kennedy, Timothy Raine, Tariq Ahmad, Dean M Allerton, Michelle Bardgett, Emma Clark, Dawn Clewes, Cristina Cotobal, Mary Doona, Jennifer A Doyle, Katherine Frith, Helen C Hancock, Ailsa L Hart, Victoria Hildreth, Peter M Irving, Sameena Iqbal, Ciara Kennedy, Andrew King, Sarah Lawrence, Charlie W Lees, Robert Lees, Laura Letchford, Trevor Liddle, James O Lindsay, Rebecca H Maier, John C Mansfield, Julian R Marchesi, Naomi McGregor, Rebecca E McIntyre, Jasmin Ostermayer, Tolulope Osunnuyi, Nicholas Powell, Natalie J Prescott, Jack Satsangi, Shriya Sharma, Tara Shrestha, Richard Alexander Speight, Michelle Strickland, James M S Wason, Kevin Whelan, Ruth C Wood, Gregory R Young, Xinyue Zhang, Miles Parkes, Christopher J Stewart, Luke Jostins-Dean, Christopher Andrew Lamb
Defining predictors of responsiveness to advanced therapies in Crohn's disease and ulcerative colitis: protocol for the IBD-RESPONSE and nested CD-metaRESPONSE prospective, multicentre, observational cohort study in precision medicine. BMJ open 14 (4) (2024)
James L Alexander, Nicola J Wyatt, Stephane S M Camuzeaux, Elena Chekmeneva, Beatriz Jiménez, Caroline J Sands, Hannah Fuller, Panteleimon G Takis, Tariq Ahmad, Jennifer A Doyle, Ailsa L Hart, Peter M Irving, Nicholas Alexander Kennedy, Charlie W Lees, James O Lindsay, Rebecca E McIntyre, Miles Parkes, Natalie J Prescott, Timothy Raine, Jack Satsangi, Richard Alexander Speight, Luke Jostins-Dean, Nicholas Powell, Julian R Marchesi, Christopher J Stewart, Christopher Andrew Lamb
Considerations for peripheral blood transport and storage during large-scale multicentre metabolome research. Gut (2023)
Marc Ferrante, Peter M Irving, Maria T Abreu, Jeffrey Axler, Xiang Gao, Qian Cao, Toshimitsu Fujii, Astrid Rausch, Joanna Torres, Ezequiel Neimark, Alexandra Song, Kori Wallace, Kristina Kligys, Sofie Berg, Xiaomei Liao, Qing Zhou, Jasmina Kalabic, Brian Feagan, Remo Panaccione
Maintenance Risankizumab Sustains Induction Response in Patients with Crohn's Disease in a Randomized Phase 3 Trial. Journal of Crohn's & colitis (2023)
Robin John Dart, Iva Zlatareva, Pierre Vantourout, Efstathios Theodoridis, Ariella Amar, Shichina Kannambath, Philip East, Timothy Recaldin, John C Mansfield, Christopher Andrew Lamb, Miles Parkes, Peter M Irving, Natalie J Prescott, Adrian C Hayday
Conserved γδ T cell selection by BTNL proteins limits progression of human inflammatory bowel disease. Science (New York, N.Y.) 381 (6663) (2023)
Peter M Irving
Thiopurines for Ulcerative Colitis: Old Favourite or Old Hat? Journal of Crohn's & colitis (2023)
Christina Kapizioni, Rofaida Desoki, Danielle Lam, Karthiha Balendran, Eman Al-Sulais, Sreedhar Subramanian, Joanna E Rimmer, Juan De La Revilla Negro, Holly Pavey, Laetitia Pele, Johanne Brooks, Gordon W Moran, Peter M Irving, Jimmy K Limdi, Christopher A Lamb, null null, Miles Parkes, Timothy Raine
Biologic therapy for inflammatory bowel disease: Real-world comparative effectiveness and impact of drug sequencing in 13,222 patients within the UK IBD BioResource. Journal of Crohn's & colitis (2023)
Samuel Hsiang Lim, Beatriz Gros, Esha Sharma, Anouk Lehmann, James O Lindsay, Louise Caulfield, Daniel R Gaya, Jo Taylor, Jimmy Limdi, Jon Kwok, Elinor Shuttleworth, Anjan Dhar, Gemma Burdge, Christian Selinger, Sara Cococcia, Charles Murray, Karthiha Balendran, Tim Raine, Becky George, Gareth Walker, Robin Aldridge, Peter M Irving, Charlie W Lees, Mark Samaan
Safety, Effectiveness, and Treatment Persistence of Subcutaneous Vedolizumab in IBD: A Multicenter Study From the United Kingdom. Inflammatory bowel diseases (2023)
Bridgette Wilson, Tokuwa Kanno, Rachael Slater, Megan Rossi, Peter M Irving, Miranda C Lomer, Christopher Sj Probert, A James Mason, Kevin Whelan
Faecal and urine metabolites, but not gut microbiota, may predict response to low FODMAP diet in irritable bowel syndrome. Alimentary pharmacology & therapeutics (2023)
James L Alexander, Nicola J Wyatt, Stephane S M Camuzeaux, Elena Chekmeneva, Beatriz Jiménez, Caroline J Sands, Hannah Fuller, Panteleimon G Takis, Tariq Ahmad, Jennifer A Doyle, Ailsa L Hart, Peter M Irving, Nicholas Alexander Kennedy, Charlie W Lees, James O Lindsay, Rebecca E McIntyre, Miles Parkes, Natalie J Prescott, Timothy Raine, Jack Satsangi, Richard Alexander Speight, Luke Jostins-Dean, Nicholas Powell, Julian R Marchesi, Christopher J Stewart, Christopher Andrew Lamb
Considerations for peripheral blood transport and storage during large-scale multicentre metabolome research. Gut (2023)
Geert R A M D'Haens, Walter Reinisch, Stefan Schreiber, Fraser Cummings, Peter M Irving, Byong Duk Ye, Dong-Hyeon Kim, Sangwook Yoon, Shomron Ben-Horin
Subcutaneous Infliximab Monotherapy Versus Combination Therapy with Immunosuppressants in Inflammatory Bowel Disease: A Post Hoc Analysis of a Randomised Clinical Trial. Clinical drug investigation (2023)
James L Alexander, Nicola J Wyatt, Stephane S M Camuzeaux, Elena Chekmeneva, Beatriz Jiménez, Caroline J Sands, Hannah Fuller, Panteleimon G Takis, Tariq Ahmad, Jennifer A Doyle, Ailsa L Hart, Peter M Irving, Nicholas Alexander Kennedy, Charlie W Lees, James O Lindsay, Rebecca E McIntyre, Miles Parkes, Natalie J Prescott, Timothy Raine, Jack Satsangi, Richard Alexander Speight, Luke Jostins-Dean, Nicholas Powell, Julian R Marchesi, Christopher J Stewart, Christopher Andrew Lamb
Considerations for peripheral blood transport and storage during large-scale multicentre metabolome research. Gut (2023)
Timothy Raine, Holly Pavey, Wendi Qian, Gordon William Moran, Sreedhar Subramanian, Lizzie Swaby, Simon P L Travis, Shahida Din, Peter M Irving, James O Lindsay, Miles Parkes, Nicholas Alexander Kennedy
Establishment of a validated central reading system for ileocolonoscopy in an academic setting. Gut 71 (4) (2022)
Sailish Honap, Lulia Al-Hillawi, Samantha Baillie, Aaron Bancil, Lawrence Matini, Rebecca Lau, Klaartje Bel Kok, Kamal V Patel, Alissa Walsh, Peter M Irving, Mark A Samaan
Ustekinumab for the treatment of moderate to severe ulcerative colitis: a multicentre UK cohort study. Frontline gastroenterology 13 (6) (2022)
Raphael P Luber, Bianca Petri, Susanna Meade, Sailish Honap, Sebastian Zeki, Krisztina B Gecse, Nyree Griffin, Peter M Irving
Positioning intestinal ultrasound in a UK tertiary centre: significant estimated clinical role and cost savings. Frontline gastroenterology 14 (1) (2022)
Óscar Palomares, Dirk Elewaut, Peter M Irving, Xavier Jaumont, Paolo Tassinari
Regulatory T cells and immunoglobulin E: A new therapeutic link for autoimmunity? Allergy 77 (11) (2022)
Marc Ferrante, Peter M Irving, Christian Philipp Selinger, Geert R A M D'Haens, Tanja Kuehbacher, Ursula E Seidler, Savion Gropper, Thomas Haeufel, Sebastiano Forgia, Silvio Danese, Jochen Klaus, Brian G Feagan
Safety and tolerability of spesolimab in patients with ulcerative colitis. Expert opinion on drug safety (2022)
Susanna Meade, Emma Routledge, Esha Sharma, Sailish Honap, Shuvra Ray, Simon H C Anderson, Jeremy Sanderson, Joel Mawdsley, Peter M Irving, Mark A Samaan
How achievable are STRIDE-II treatment targets in real-world practice and do they predict long-term treatment outcomes? Frontline gastroenterology 14 (4) (2022)
Susanna Meade, Kamal V Patel, Raphael P Luber, Dearbhaile O'Hanlon, Andra Caracostea, Polychronis Pavlidis, Sailish Honap, Cheran Anandarajah, Nyree Griffin, Sebastian Zeki, Shuvra Ray, Joel Mawdsley, Mark A Samaan, Simon H Anderson, Amir Darakhshan, Katie Adams, Andrew Williams, Jeremy D Sanderson, Miranda Lomer, Peter M Irving
A retrospective cohort study: pre-operative oral enteral nutritional optimisation for Crohn's disease in a UK tertiary IBD centre. Alimentary pharmacology & therapeutics 56 (4) (2022)
Stefan Schreiber, Peter M Irving, Ala I Sharara, Maria Dolores Martin-Arranz, Xavier Hébuterne, Plamen Penchev, Silvio Danese, Prodromos Anthopoulos, Gamar Akhundova-Unadkat, Filip Baert
Review article: randomised controlled trials in inflammatory bowel disease-common challenges and potential solutions. Alimentary pharmacology & therapeutics 55 (6) (2022)
Peter M Irving, Yvette Leung, Marla C Dubinsky
Review article: guide to tofacitinib dosing in patients with ulcerative colitis. Alimentary pharmacology & therapeutics 56 (7) (2022)
Franco Torrente, Susanna Meade, Eric I Benchimol, Lissy de Ridder, Nicholas M Croft, Jochen Kammermeier, David R Mack, Renz C W Klomberg, Dan Turner, David C Wilson, Javier Martín-de-Carpi, Jiri Bronsky, Jorge Amil Dias, Gregor Walker, Cornelia Heleen van Ommen, Michael P Powar, Natasha Burgess, Peter M Irving, Mark A Samaan, Richard Hansen
Thromboprophylaxis Use in Paediatric Inflammatory Bowel Disease: An International RAND Appropriateness Panel. Journal of Crohn's & colitis 16 (10) (2022)
Raphael P Luber, Bianca Petri, Susanna Meade, Sailish Honap, Sebastian Zeki, Krisztina B Gecse, Nyree Griffin, Peter M Irving
Positioning intestinal ultrasound in a UK tertiary centre: significant estimated clinical role and cost savings. Frontline gastroenterology 14 (1) (2022)
Raphael P Luber, Rhona O'Neill, Sukhpreet Singh, Esha Sharma, Georgina Cunningham, Sailish Honap, Susanna Meade, Shuvra Ray, Simon H Anderson, Joel Mawdsley, Jeremy D Sanderson, Mark A Samaan, Zehra Arkir, Peter M Irving
An observational study of switching infliximab biosimilar: no adverse impact on inflammatory bowel disease control or drug levels with first or second switch. Alimentary pharmacology & therapeutics 54 (5) (2021)
Nicholas Alexander Kennedy, Simeng Lin, James R Goodhand, Neil Chanchlani, Benjamin Hamilton, Claire M Bewshea, Rachel Nice, Desmond Chee, J R Fraser Cummings, Aileen Fraser, Peter M Irving, Nikolaos Kamperidis, Klaartje B Kok, Christopher Andrew Lamb, Jonathan Macdonald, Shameer J Mehta, Richard C G Pollok, Timothy Raine, Philip J Smith, Ajay Mark Verma, Simon Jochum, Timothy James McDonald, Shaji Sebastian, Charlie W Lees, Nicholas Powell, Tariq Ahmad, null null
Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD. Gut 70 (10) (2021)
Timothy Raine, Maria Angeliki Gkini, Peter M Irving, Arvind Kaul, Eleanor Korendowych, Philip M Laws, Amy Charlotte Foulkes
Maintaining Clinical Freedom Whilst Achieving Value in Biologics Prescribing: An Integrated Cross-Specialty Consensus of UK Dermatologists, Rheumatologists and Gastroenterologists. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 35 (2) (2021)
Nicholas Alexander Kennedy, James R Goodhand, Claire M Bewshea, Rachel Nice, Desmond Chee, Simeng Lin, Neil Chanchlani, Jeffrey Butterworth, Rachel Cooney, Nicholas M Croft, Ailsa L Hart, Peter M Irving, Klaartje B Kok, Christopher Andrew Lamb, Jimmy K Limdi, Jonathan Macdonald, Dermot P B McGovern, Shameer J Mehta, Charles D R Murray, Kamal V Patel, Richard C G Pollok, Timothy Raine, Richard Kay Russell, Christian Philipp Selinger, Philip J Smith, Jack Bowden, Timothy James McDonald, Charlie W Lees, Shaji Sebastian, Nicholas Powell, Tariq Ahmad, null null
Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab. Gut 70 (5) (2021)
Alastair G Proudfoot, Antonis Kalakoutas, Susanna Meade, Mark J D Griffiths, Mir Babar Basir, Francesco Burzotta, Sharon Chih, Eddy Fan, Jonathan Haft, Nasrien Ibrahim, Natalie Kruit, Hoong Sern Lim, David A Morrow, Jun Nakata, Susanna Price, Carolyn M Rosner, Robert O Roswell, Mark A Samaan, Marc D Samsky, Holger Thiele, Alexander G Truesdell, Sean van Diepen, Michelle Doughty Voeltz, Peter M Irving
Contemporary Management of Cardiogenic Shock: A RAND Appropriateness Panel Approach. Circulation. Heart failure (2021)
Peter M Irving, Kevin Barrett, Monica Nijher, Simon de Lusignan
Prevalence of depression and anxiety in people with inflammatory bowel disease and associated healthcare use: population-based cohort study. Evidence-based mental health (2021)
Sailish Honap, Polychronis Pavlidis, Peter M Irving
Editorial: is tofacitinib another rescue option for acute severe ulcerative colitis? Alimentary pharmacology & therapeutics 54 (3) (2021)
Peter M Irving, Simon de Lusignan, Daniel Tang, Monica Nijher, Kevin Barrett
Risk of common infections in people with inflammatory bowel disease in primary care: a population-based cohort study. BMJ open gastroenterology 8 (1) (2021)
Nicholas Alexander Kennedy, Gareth-Rhys Jones, Christopher Andrew Lamb, Richard Appleby, Ian Arnott, Robert Mark Beattie, Stuart Bloom, Alenka J Brooks, Rachel Cooney, Robin John Dart, Cathryn M Edwards, Aileen Fraser, Daniel R Gaya, Subrata Ghosh, Kay Greveson, Richard Hansen, Ailsa L Hart, A Barney Hawthorne, Bu' Hussain Hayee, Jimmy K Limdi, Charles D R Murray, Gareth C Parkes, Miles Parkes, Kamal Patel, Richard C G Pollok, Nicholas Powell, Chris S Probert, Timothy Raine, Shaji Sebastian, Christian Philipp Selinger, Philip J Smith, Catherine Stansfield, Lisa Younge, James O Lindsay, Peter M Irving, Charlie W Lees
British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic. Gut 69 (6) (2020)
Charlie W Lees, Peter M Irving, Laurent Beaugerie
COVID-19 and IBD drugs: should we change anything at the moment? Gut 70 (4) (2020)
Jennie N Clough, Omer S Omer, Scott Tasker, Graham M Lord, Peter M Irving
Regulatory T-cell therapy in Crohn's disease: challenges and advances. Gut 69 (5) (2020)
Mark A Samaan, Georgina Cunningham, Aravind Gokul Tamilarasan, Luisa Beltran, Polychronis Pavlidis, Shuvra Ray, Joel Mawdsley, Simon H Anderson, Jeremy D Sanderson, Zehra Arkir, Peter M Irving
Therapeutic thresholds for golimumab serum concentrations during induction and maintenance therapy in ulcerative colitis: results from the GO-LEVEL study. Alimentary pharmacology & therapeutics 52 (2) (2020)
Shahida Din, Alexandra J Kent, Richard C G Pollok, Susanna Meade, Nicholas Alexander Kennedy, Ian Arnott, Robert Mark Beattie, Felix Chua, Rachel Cooney, Robin John Dart, James B Galloway, Daniel R Gaya, Subrata Ghosh, Mark J D Griffiths, Laura Hancock, Richard Hansen, Ailsa L Hart, Christopher Andrew Lamb, Charlie W Lees, Jimmy K Limdi, James O Lindsay, Kamal V Patel, Nicholas Powell, Charles D R Murray, Chris S Probert, Timothy Raine, Christian Philipp Selinger, Shaji Sebastian, Philip J Smith, Phillip Tozer, Andrew Ustianowski, Lisa Younge, Mark A Samaan, Peter M Irving
Adaptations to the British Society of Gastroenterology guidelines on the management of acute severe UC in the context of the COVID-19 pandemic: a RAND appropriateness panel. Gut 69 (10) (2020)
Raphael Luber, Esha Sharma, Peter M Irving, Mark A Samaan
Striking the balance with intravenous iron: too much or never enough? Frontline gastroenterology 12 (5) (2020)
Esha Sharma, Susanna Meade, Francesca D'Errico, Polychronis Pavlidis, Raphael Luber, Sebastian Zeki, Katie Hill, Alexa Duff, Dearbhaile O'Hanlon, Sherill Tripoli, Anna Stanton, Andra Caracostea, Sailish Honap, Rebecca Reynolds, Simon Anderson, Shuvra Ray, Joel Mawdsley, Jeremy Sanderson, Mark A Samaan, Peter M Irving
The effects of COVID-19 on IBD prescribing and service provision in a UK tertiary centre. GastroHep 2 (6) (2020)
Richard Hansen, Susanna Meade, Robert Mark Beattie, Marcus Karl-Heinz Auth, Nicholas M Croft, Philip Davies, David Devadason, Conor Doherty, Jenny Epstein, Lucy Howarth, Fevronia Kiparissi, Rafeeq Muhammed, Vinay Shivamurthy, Christine H Spray, Michael P Stanton, Franco Torrente, Arun Urs, David C Wilson, Peter M Irving, Mark A Samaan, Jochen Kammermeier
Adaptations to the current ECCO/ESPGHAN guidelines on the management of paediatric acute severe colitis in the context of the COVID-19 pandemic: a RAND appropriateness panel. Gut 70 (6) (2020)
Nicholas Alexander Kennedy, Richard Hansen, Lisa Younge, Joel Mawdsley, Robert Mark Beattie, Shahida Din, Christopher Andrew Lamb, Philip J Smith, Christian Selinger, Jimmy Limdi, Tariq H Iqbal, Alan Lobo, Rachel Cooney, Oliver Brain, Daniel R Gaya, Charles Murray, Richard Pollok, Alexandra Kent, Tim Raine, Neeraj Bhala, James O Lindsay, Peter M Irving, Charlie W Lees, Shaji Sebastian
Organisational changes and challenges for inflammatory bowel disease services in the UK during the COVID-19 pandemic. Frontline gastroenterology 11 (5) (2020)
Thomas Langford, Zehra Arkir, Anastasia Chalkidou, Kate Goddard, Lamprini Kaftantzi, Mark A Samaan, Peter M Irving
The Clinical and Cost-Effectiveness of 4 Enzyme-Linked Immunosorbent Assay Kits for Monitoring Infliximab in Crohn Disease Patients: Protocol for a Validation Study. JMIR research protocols 7 (10) (2018)